Anne R. Karow‐Zwick

High-concentration protein formulations: How high is high?

Patrick Garidel, Alexander Kühn, Lars V. Schäfer et al. · European Journal of Pharmaceutics and Biopharmaceutics · 2017 · 188 citations

Pharmacy, Biochemistry, Pharmaceutics +8

Prediction and Reduction of the Aggregation of Monoclonal Antibodies

Rob van der Kant, Anne R. Karow‐Zwick, Joost Van Durme et al. · Journal of Molecular Biology · 2017 · 146 citations · Full text

Pharmacy, Biochemistry, Biotechnology +17

Improved Solution-State Properties of Monoclonal Antibodies by Targeted Mutations

Alexander Kühn, Sebastian Kube, Anne R. Karow‐Zwick et al. · The Journal of Physical Chemistry B · 2017 · 29 citations

Pharmacy, Biophysics, Molecular Biology +17

Adaption of human antibody λ and κ light chain architectures to CDR repertoires

Rob van der Kant, Joschka Bauer, Anne R. Karow‐Zwick et al. · Protein Engineering Design and Selection · 2019 · 21 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Rational optimization of a monoclonal antibody improves the aggregation propensity and enhances the CMC properties along the entire pharmaceutical process chain

Joschka Bauer, Sven Mathias, Sebastian Kube et al. · mAbs · 2020 · 21 citations · Full text

Pharmacy, Molecular Pharmaceutics, Antibody Engineering +12